. 2019 Sep 2;11(9):453. doi: 10.3390/pharmaceutics11090453

Table 2.

Baseline CGI-S and HDRS-17 scores in the pharmacogenetic-guided and control groups in the three clinical studies.

Study	Variable	PGx-Guided	Control	p-Value
Korean study [24]	CGI-S, mean ± SD	4.90 ± 0.80	4.60 ± 0.70	0.063
Korean study [24]	HDRS-17, mean ± SD	24.50 ± 4.60	23.10 ± 5.00	0.159
AB-GEN study [23]	CGI-S, mean ± SD	4.50 ± 0.62	4.40 ± 0.57	0.166
AB-GEN study [23]	HDRS-17, mean ± SD	19.47 ± 5.96	19.01 ± 5.71	0.482
GENEPSI study [25]	CGI-S, mean ± SD	4.29 ± 0.57	4.26 ± 0.72	0.836
GENEPSI study [25]	HDRS-17, mean ± SD	na	na	na

na: not assessed.